Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Warren Nighan Insider Profile
4 Followers
Warren Nighan, EVP, Global QA/RA at Haemonetics, holds 45.88K shares in AngioDynamics (Ticker: ANGO), holds 15.24K shares in Haemonetics (Ticker: HAE). Most recently, Warren Nighan Bought ― shares of AngioDynamics on Oct 10, 2024 for an estimated value of 5.29K.
Warren Nighan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Warren Nighan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Warren Nighan
Warren Nighan's Trading History
Haemonetics
Jan 30, 2013
EVP, Global QA/RA
Uninformative Sell
12.75K
$1.29M
AngioDynamics
Oct 10, 2024
SVP Quality and Regulatory
Informative Buy
5.29K
$309.21K
List of latest transactions for each holding click on a transaction to see Warren Nighan's performance on stock
You May Also Like
Warren Nighan insider profile FAQ
What is the percentage of profitable transactions made by Warren Nighan?
The percentage of profitable transactions made by Warren Nighan is ―.
What is the average return per transaction made by Warren Nighan?
The average return per transaction made by Warren Nighan is ―.
What stocks does Warren Nighan hold?
Warren Nighan holds: HAE, ANGO stocks.
What was Warren Nighan’s latest transaction?
Warren Nighan latest transaction was an Informative Buy of $5.29K.
What was Warren Nighan's most profitable transaction?
Warren Nighan’s most profitable transaction was an Informative Buy of ANGO stock on October 10, 2024. The return on the trade was 17.20%.
What is Warren Nighan's role in Haemonetics?
Warren Nighan's role in Haemonetics is EVP, Global QA/RA.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.